Stereotypical Prolonged Seizure clinical trials

Explore recruiting stereotypical prolonged seizure clinical trials.

Recruiting stereotypical prolonged seizure studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Stereotypical Prolonged Seizure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

France, Spain, Germany, Hungary, Czechia, Bulgaria +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

AN OPEN-LABEL, MULTICENTER, OUTPATIENT EXTENSION STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF STACCATO ALPRAZOLAM IN STUDY PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH STEREOTYPICAL PROLONGED SEIZURES

Poland, Hungary, Czechia, Spain, Germany, Bulgaria +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Stereotypical Prolonged Seizure trials by city

Stereotypical Prolonged Seizure in Toronto Stereotypical Prolonged Seizure in Vancouver Stereotypical Prolonged Seizure in Montreal Stereotypical Prolonged Seizure in Calgary Stereotypical Prolonged Seizure in Edmonton Stereotypical Prolonged Seizure in Ottawa Stereotypical Prolonged Seizure in Winnipeg Stereotypical Prolonged Seizure in Quebec City Stereotypical Prolonged Seizure in Hamilton Stereotypical Prolonged Seizure in Kitchener Stereotypical Prolonged Seizure in London Stereotypical Prolonged Seizure in Halifax Stereotypical Prolonged Seizure in New York Stereotypical Prolonged Seizure in Los Angeles Stereotypical Prolonged Seizure in Chicago Stereotypical Prolonged Seizure in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease